ACADIA Pharmaceuticals Inc. (ACAD)
USD 14.91
(2.33%)
USD 14.91
(2.33%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 47.8 Million USD | -9.29% |
| 2022 | 52.69 Million USD | -6.11% |
| 2021 | 56.12 Million USD | 26.24% |
| 2020 | 44.46 Million USD | 598.95% |
| 2019 | 6.36 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 32 Thousand USD | -67.35% |
| 2009 | 98 Thousand USD | -77.21% |
| 2008 | 430 Thousand USD | -62.8% |
| 2007 | 1.15 Million USD | -16.17% |
| 2006 | 1.37 Million USD | 54.67% |
| 2005 | 891.6 Thousand USD | -14.6% |
| 2004 | 1.04 Million USD | -35.72% |
| 2003 | 1.62 Million USD | -53.04% |
| 2002 | 3.45 Million USD | 161.4% |
| 2001 | 1.32 Million USD | -77.15% |
| 2000 | 5.78 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 47.18 Million USD | -4.07% |
| 2024 Q1 | 49.18 Million USD | 0.0% |
| 2023 Q1 | 51.44 Million USD | -2.38% |
| 2023 Q4 | 47.8 Million USD | -0.63% |
| 2023 Q3 | 48.1 Million USD | -3.36% |
| 2023 FY | 47.8 Million USD | -9.29% |
| 2023 Q2 | 49.77 Million USD | -3.23% |
| 2022 Q2 | 54.69 Million USD | -1.41% |
| 2022 Q1 | 55.47 Million USD | -1.15% |
| 2022 FY | 52.69 Million USD | -6.11% |
| 2022 Q4 | 52.69 Million USD | -2.0% |
| 2022 Q3 | 53.76 Million USD | -1.69% |
| 2021 Q4 | 56.12 Million USD | -2.69% |
| 2021 Q1 | 60.58 Million USD | 36.26% |
| 2021 FY | 56.12 Million USD | 26.24% |
| 2021 Q2 | 59.13 Million USD | -2.39% |
| 2021 Q3 | 57.67 Million USD | -2.46% |
| 2020 Q4 | 44.46 Million USD | -1.95% |
| 2020 FY | 44.46 Million USD | 598.95% |
| 2020 Q1 | 6.09 Million USD | -4.26% |
| 2020 Q2 | 5.66 Million USD | -6.91% |
| 2020 Q3 | 45.34 Million USD | 699.84% |
| 2019 Q4 | 6.36 Million USD | -0.28% |
| 2019 Q2 | 6.74 Million USD | -0.18% |
| 2019 FY | 6.36 Million USD | 0.0% |
| 2019 Q3 | 6.37 Million USD | -5.38% |
| 2019 Q1 | 6.75 Million USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 100.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | -32 Thousand USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 FY | - USD | -100.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | -100.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2010 Q3 | 41 Thousand USD | -19.61% |
| 2010 Q2 | 51 Thousand USD | -21.54% |
| 2010 FY | 32 Thousand USD | -67.35% |
| 2010 Q4 | 32 Thousand USD | -21.95% |
| 2010 Q1 | 65 Thousand USD | -33.67% |
| 2009 Q3 | 154 Thousand USD | -32.46% |
| 2009 Q2 | 228 Thousand USD | -29.63% |
| 2009 FY | 98 Thousand USD | -77.21% |
| 2009 Q1 | 324 Thousand USD | -24.65% |
| 2009 Q4 | 98 Thousand USD | -36.36% |
| 2008 Q3 | 560 Thousand USD | -23.29% |
| 2008 Q4 | 430 Thousand USD | -23.21% |
| 2008 FY | 430 Thousand USD | -62.8% |
| 2008 Q1 | 939 Thousand USD | -18.77% |
| 2008 Q2 | 730 Thousand USD | -22.26% |
| 2007 Q2 | 1.43 Million USD | -4.26% |
| 2007 Q4 | 1.15 Million USD | -7.89% |
| 2007 Q3 | 1.25 Million USD | -12.79% |
| 2007 Q1 | 1.5 Million USD | 8.99% |
| 2007 FY | 1.15 Million USD | -16.17% |
| 2006 Q2 | 883 Thousand USD | 20.46% |
| 2006 Q3 | 1.14 Million USD | 29.56% |
| 2006 Q4 | 1.37 Million USD | 20.54% |
| 2006 FY | 1.37 Million USD | 54.67% |
| 2006 Q1 | 733 Thousand USD | -17.79% |
| 2005 Q4 | 891.6 Thousand USD | -3.79% |
| 2005 FY | 891.6 Thousand USD | -14.6% |
| 2005 Q1 | 854 Thousand USD | -18.2% |
| 2005 Q2 | 818.9 Thousand USD | -4.11% |
| 2005 Q3 | 926.7 Thousand USD | 13.16% |
| 2004 Q3 | 1.02 Million USD | 8.45% |
| 2004 Q4 | 1.04 Million USD | 1.72% |
| 2004 Q1 | 876.5 Thousand USD | -46.03% |
| 2004 FY | 1.04 Million USD | -35.72% |
| 2004 Q2 | 946.3 Thousand USD | 7.96% |
| 2003 Q4 | 1.62 Million USD | 0.0% |
| 2003 FY | 1.62 Million USD | -53.04% |
| 2002 FY | 3.45 Million USD | 161.4% |
| 2001 FY | 1.32 Million USD | -77.15% |
| 2000 FY | 5.78 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -42.623% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -4148.889% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -217172.727% |
| Autolus Therapeutics plc | 47.91 Million USD | 0.238% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -6867.93% |
| Shattuck Labs, Inc. | 3.4 Million USD | -1303.406% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -114.1% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -1375.932% |
| Aptose Biosciences Inc. | 621 Thousand USD | -7597.262% |
| Precision BioSciences, Inc. | 7.72 Million USD | -518.93% |
| Dyadic International, Inc. | 88.87 Thousand USD | -53686.43% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -79.026% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -34537.681% |
| Nektar Therapeutics | 112.62 Million USD | 57.558% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -409.323% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -48182.828% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -874.317% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | 63.417% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -489.759% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -65379.452% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 34.67 Million USD | -37.863% |
| INmune Bio, Inc. | 397 Thousand USD | -11940.302% |
| Opthea Limited | 200.53 Million USD | 76.164% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | 3.962% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -221.129% |
| Verastem, Inc. | 40.08 Million USD | -19.244% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -985.87% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -375.433% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -628.547% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -730.582% |
| NextCure, Inc. | 5.94 Million USD | -703.496% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -52938.036% |
| Organovo Holdings, Inc. | 888 Thousand USD | -5282.883% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Arvinas, Inc. | 800 Thousand USD | -5875.0% |
| Ovid Therapeutics Inc. | 30 Million USD | -59.333% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -152.977% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -95.23% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | 36.856% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -84.506% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -38.326% |
| Senti Biosciences, Inc. | 33.53 Million USD | -42.525% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -17802.622% |
| PureTech Health plc | 18.25 Million USD | -161.918% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -32865.517% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -327.129% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | 38.975% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 2.57 Million USD | -1756.311% |
| Beam Therapeutics Inc. | 159.91 Million USD | 70.108% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | 32.861% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -106.703% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | 48.62% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 40.14 Million USD | -19.071% |
| Mesoblast Limited | 100.48 Million USD | 52.43% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | 74.965% |
| Fate Therapeutics, Inc. | 97.36 Million USD | 50.904% |
| MediWound Ltd. | 6.35 Million USD | -652.756% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | 52.484% |
| Fortress Biotech, Inc. | 60.85 Million USD | 21.454% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 86.043% |
| Achilles Therapeutics plc | 1.07 Million USD | -4342.379% |
| Seres Therapeutics, Inc. | 101.54 Million USD | 52.927% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -494.01% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | 15.984% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -582.272% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -60.3% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 92.588% |
| FibroGen, Inc. | 89.69 Million USD | 46.709% |
| Celcuity Inc. | 37.03 Million USD | -29.066% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -1002.144% |
| ContextLogic Inc. | 6 Million USD | -696.667% |
| GH Research PLC | 631 Thousand USD | -7475.277% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -1157.564% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -129089.189% |
| ImmuCell Corporation | 10.54 Million USD | -353.489% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -2314.141% |
| Amarin Corporation plc | 8.73 Million USD | -447.099% |
| TG Therapeutics, Inc. | 100.11 Million USD | 52.256% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -785.677% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -2535.061% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -30.762% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -9145.648% |
| Aptorum Group Limited | 3.05 Million USD | -1462.858% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -56.342% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 94.108% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -15026.582% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | 54.306% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -124733.512% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -972.23% |
| Ardelyx, Inc. | 51.54 Million USD | 7.269% |
| Ainos, Inc. | 5.92 Million USD | -707.22% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -122.875% |
| Prothena Corporation plc | 10.72 Million USD | -345.854% |
| HilleVax, Inc. | 25.24 Million USD | -89.352% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -140.794% |
| Celularity Inc. | 26.17 Million USD | -82.603% |
| Rallybio Corporation | 173 Thousand USD | -27530.058% |
| Cue Biopharma, Inc. | 4.2 Million USD | -1037.554% |
| Omeros Corporation | 329.7 Million USD | 85.502% |
| Humacyte, Inc. | 38.6 Million USD | -23.834% |
| Immunocore Holdings plc | 82.64 Million USD | 42.162% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -2863.422% |
| Blueprint Medicines Corporation | 610.96 Million USD | 92.176% |
| IO Biotech, Inc. | 1.83 Million USD | -2499.239% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -3178.464% |
| Summit Therapeutics Inc. | 103.29 Million USD | 53.723% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | 49.784% |
| Scholar Rock Holding Corporation | 48.68 Million USD | 1.816% |
| Pulmatrix, Inc. | 8.32 Million USD | -474.036% |
| Elicio Therapeutics, Inc. | 6 Million USD | -695.738% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | 12.406% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -269.255% |
| Acelyrin, Inc. | 1.19 Million USD | -3903.35% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | 50.593% |
| Cytokinetics, Incorporated | 607.37 Million USD | 92.13% |
| Vor Biopharma Inc. | 31.83 Million USD | -50.173% |
| Evogene Ltd. | 10.65 Million USD | -348.7% |
| Replimune Group, Inc. | 71.99 Million USD | 33.602% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -6197.76% |
| PDS Biotechnology Corporation | 19.5 Million USD | -145.051% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -181469.551% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 97.246% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 6.62 Million USD | -621.183% |
| Galectin Therapeutics Inc. | 71.74 Million USD | 33.371% |
| Atai Life Sciences N.V. | 15.21 Million USD | -214.246% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -18645.098% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -2944.586% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -10.776% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -11539.799% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -3391.6% |
| MiMedx Group, Inc. | 48.09 Million USD | 0.622% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -7108.577% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | 73.157% |
| PTC Therapeutics, Inc. | 284.21 Million USD | 83.182% |
| Mereo BioPharma Group plc | 5.3 Million USD | -801.887% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -8029.252% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -110.619% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Allakos Inc. | 38.21 Million USD | -25.082% |
| scPharmaceuticals Inc. | 38.81 Million USD | -23.161% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -453.946% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Precigen, Inc. | 5.89 Million USD | -710.857% |
| XOMA Corporation | 118.51 Million USD | 59.669% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -374.724% |
| Incyte Corporation | 29.16 Million USD | -63.912% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -28.914% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -505.14% |
| Seer, Inc. | 25.96 Million USD | -84.101% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 223 Million USD | 78.566% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -91.476% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -318566.667% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -17082.501% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Novavax, Inc. | 168.01 Million USD | 71.55% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -35002.406% |
| UroGen Pharma Ltd. | 98.55 Million USD | 51.497% |
| Sutro Biopharma, Inc. | 149.11 Million USD | 67.944% |
| Entera Bio Ltd. | 256 Thousand USD | -18571.875% |
| Lisata Therapeutics, Inc. | 137.00 USD | -34890410.949% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -901.467% |
| Chimerix, Inc. | 125 Thousand USD | -38140.0% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -7345.483% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | 65.438% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 99.064% |
| AnaptysBio, Inc. | 16.03 Million USD | -198.061% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 7000.00 USD | -682757.143% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -3244.997% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -284.43% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -71344.586% |
| AbCellera Biologics Inc. | 71.22 Million USD | 32.886% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -2479.601% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 3.91 Million USD | -1121.358% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 40.08 Million USD | -19.261% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | 40.676% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | 7.88% |
| bluebird bio, Inc. | 224.41 Million USD | 78.701% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 91.941% |
| DBV Technologies S.A. | 4.52 Million USD | -956.12% |
| Fortress Biotech, Inc. | 60.85 Million USD | 21.454% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -669.355% |
| CorMedix Inc. | 517.01 Thousand USD | -9145.415% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 87.33% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -1168.241% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -4505.01% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -2683.925% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -5050.862% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -443.862% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -173.659% |
| Onconetix, Inc. | 118.85 Thousand USD | -40116.394% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 4.35 Million USD | -997.085% |
| Adagene Inc. | 13.54 Million USD | -253.027% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | 76.905% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -71409.784% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 90.785% |
| Verve Therapeutics, Inc. | 64.71 Million USD | 26.138% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -179.647% |
| SciSparc Ltd. | 24 Thousand USD | -199066.667% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | 41.719% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -1149.673% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -230.685% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | 76.313% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 97.96% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -207726.087% |
| 2seventy bio, Inc. | 244.01 Million USD | 80.411% |
| ADMA Biologics, Inc. | 130.59 Million USD | 63.398% |
| Clene Inc. | 7.15 Million USD | -568.345% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -1315.768% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | 80.696% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -4241.508% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -18084.239% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | 75.184% |
| Absci Corporation | 4.66 Million USD | -925.751% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 98.232% |
| Surrozen, Inc. | 882 Thousand USD | -5319.501% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -84.499% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -107.6% |
| Cingulate Inc. | 135.09 Thousand USD | -35281.461% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 30.99 Million USD | -54.228% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -88.345% |
| Innoviva, Inc. | 446.23 Million USD | 89.288% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -174.13% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | 20.757% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -4628.301% |
| AlloVir, Inc. | 16.64 Million USD | -187.122% |
| Century Therapeutics, Inc. | 46.65 Million USD | -2.448% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -640564.79% |
| Kura Oncology, Inc. | 9.33 Million USD | -412.216% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -605.743% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -10291.304% |
| Heron Therapeutics, Inc. | 173.75 Million USD | 72.49% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -1079.007% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -32428.292% |
| HCW Biologics Inc. | 6.3 Million USD | -658.21% |
| C4 Therapeutics, Inc. | 65.75 Million USD | 27.308% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -4.611% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 89.902% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -77628.633% |
| Histogen Inc. | 4.38 Million USD | -990.328% |
| Surrozen, Inc. | 882 Thousand USD | -5319.501% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | 100 Million USD | 52.2% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -1812.008% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -51240.437% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | 26.037% |
| Avalo Therapeutics, Inc. | 2 Million USD | -2290.0% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 96.587% |
| Turnstone Biologics Corp. | 1.18 Million USD | -3920.185% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -43753.211% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | 41.714% |
| Exelixis, Inc. | 189.94 Million USD | 74.835% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -11.482% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -88.159% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Alkermes plc | 287.73 Million USD | 83.387% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -2535.061% |
| Arcellx, Inc. | 50.84 Million USD | 5.981% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | 68.879% |
| Insmed Incorporated | 1.19 Billion USD | 95.994% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -3178.464% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -125.068% |
| Moolec Science SA | 99.04 Thousand USD | -48160.404% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -73.057% |
| Geron Corporation | 35.05 Million USD | -36.373% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -7987.986% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -11.489% |
| Royalty Pharma plc | 6.13 Billion USD | 99.221% |
| OmniAb, Inc. | 22.07 Million USD | -116.535% |
| Alector, Inc. | 30.45 Million USD | -56.948% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -2811.084% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -106.497% |
| Humacyte, Inc. | 38.6 Million USD | -23.834% |
| Structure Therapeutics Inc. | 4.01 Million USD | -1091.129% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 88.795% |
| 89bio, Inc. | 24.79 Million USD | -92.781% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 16.87 Million USD | -183.343% |
| Immunic, Inc. | 639 Thousand USD | -7380.438% |
| Veracyte, Inc. | 7.52 Million USD | -535.216% |
| Genelux Corporation | 1.86 Million USD | -2461.629% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -4531.783% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -36426.749% |
| Immunovant, Inc. | - USD | -Infinity% |
| Vericel Corporation | 81.85 Million USD | 41.605% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 97.072% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -694.68% |
| XBiotech Inc. | - USD | -Infinity% |
| Agenus Inc. | 137.32 Million USD | 65.192% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -79803.714% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -5.668% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -6.692% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -35047.059% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -10544.623% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -663.091% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -3863.516% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -9655.102% |
| United Therapeutics Corporation | 300 Million USD | 84.067% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | 71.223% |
| XOMA Corporation | 118.51 Million USD | 59.669% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 117.62 Million USD | 59.363% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -752.05% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -137.823% |
| uniQure N.V. | 130.06 Million USD | 63.249% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -487.079% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -31713.432% |
| Windtree Therapeutics, Inc. | 15 Million USD | -218.667% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | 18.416% |
| Pluri Inc. | 29.05 Million USD | -64.527% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| MeiraGTx Holdings plc | 72.11 Million USD | 33.721% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -1236.315% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Sana Biotechnology, Inc. | 90.9 Million USD | 47.415% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 87.676% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -752.05% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -10091.898% |
| Nutriband Inc. | 79.82 Thousand USD | -59780.24% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -966.012% |
| Compugen Ltd. | 719 Thousand USD | -6548.122% |
| Roivant Sciences Ltd. | 477.85 Million USD | 89.997% |
| ProKidney Corp. | 3.61 Million USD | -1224.1% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -72889.357% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -29.757% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -5574.338% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -843.545% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Biomea Fusion, Inc. | 7.83 Million USD | -510.473% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -2123.256% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -314.859% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -377.761% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | 43.469% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -315.472% |
| Imunon, Inc. | 1.13 Million USD | -4095.584% |
| BioAtla, Inc. | 836 Thousand USD | -5617.703% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | 45.895% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -915.078% |
| Zura Bio Limited | - USD | -Infinity% |
| aTyr Pharma, Inc. | 13.76 Million USD | -247.207% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | 58.608% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -136.575% |
| Galecto, Inc. | 66 Thousand USD | -72324.242% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -230.685% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 96.812% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | 51.964% |
| PolyPid Ltd. | 6.37 Million USD | -649.334% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | 47.708% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 14.64 Million USD | -226.458% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -31766.667% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -35002.406% |
| Instil Bio, Inc. | 81.42 Million USD | 41.297% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -7108.577% |
| OncoCyte Corporation | 2.2 Million USD | -2068.784% |
| Elevation Oncology, Inc. | 30.13 Million USD | -58.609% |
| Purple Biotech Ltd. | 163 Thousand USD | -29225.153% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -1785.602% |
| MacroGenics, Inc. | 30.19 Million USD | -58.299% |
| Verona Pharma plc | 48.37 Million USD | 1.187% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -5023.258% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -418.663% |
| Aditxt, Inc. | 1.04 Million USD | -4488.459% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -81.418% |
| Curis, Inc. | 1.48 Million USD | -3110.208% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -6750.935% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -796566.667% |
| BeiGene, Ltd. | 197.61 Million USD | 75.812% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -3467.164% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -56135.294% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -1168.914% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | 9.226% |
| Adicet Bio, Inc. | 17.7 Million USD | -170.011% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -247.965% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 89.77 Million USD | 46.755% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -115.461% |
| Invivyd, Inc. | 722 Thousand USD | -6520.499% |
| Relay Therapeutics, Inc. | 48.5 Million USD | 1.447% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -1634797.887% |
| Moolec Science SA | 99.04 Thousand USD | -48160.404% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -13.842% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -395.902% |
| Vir Biotechnology, Inc. | 111.67 Million USD | 57.196% |
| Evaxion Biotech A/S | 8.48 Million USD | -463.098% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | 36.203% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -668.983% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -103.067% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -26455.556% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -5638.295% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -1399.373% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -5006.838% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -255.681% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -0.515% |
| ImmunityBio, Inc. | 836.95 Million USD | 94.289% |
| Korro Bio, Inc. | 31.21 Million USD | -53.127% |
| Kineta, Inc. | 150 Thousand USD | -31766.667% |
| BioVie Inc. | 349.89 Thousand USD | -13561.28% |
| Codexis, Inc. | 12.24 Million USD | -290.427% |
| Celularity Inc. | 26.17 Million USD | -82.603% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -27005.957% |
| Cibus, Inc. | 17.67 Million USD | -170.454% |
| Annexon, Inc. | 29.19 Million USD | -63.755% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -4160.25% |
| Eyenovia, Inc. | 8.95 Million USD | -433.647% |
| Puma Biotechnology, Inc. | 65.65 Million USD | 27.2% |
| NeurAxis, Inc. | 27.07 Thousand USD | -176472.716% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -4430.806% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -8817.91% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -150489.125% |
| Notable Labs, Ltd. | 1.52 Million USD | -3032.372% |
| IN8bio, Inc. | 3.37 Million USD | -1314.62% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -14978.864% |
| Vera Therapeutics, Inc. | 49.87 Million USD | 4.164% |
| Lumos Pharma, Inc. | 6 Million USD | -696.667% |
| Liquidia Corporation | 2.36 Million USD | -1921.997% |
| Mustang Bio, Inc. | 1.97 Million USD | -2316.582% |
| Quantum-Si incorporated | 13.73 Million USD | -247.965% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -587.473% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -418.663% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -129089.189% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -239667.255% |
| Vaxcyte, Inc. | 22.11 Million USD | -116.182% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -397.709% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -381.37% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -185.502% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -36669.231% |
| PepGen Inc. | 17.1 Million USD | -179.532% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -9984.388% |
| Solid Biosciences Inc. | 23.94 Million USD | -99.657% |
| Palisade Bio, Inc. | 90 Thousand USD | -53011.111% |
| Nutriband Inc. | 79.82 Thousand USD | -59780.24% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -1048.251% |
| Belite Bio, Inc | 578 Thousand USD | -8169.896% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -367592.308% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -24539.175% |
| Altimmune, Inc. | 175 Thousand USD | -27214.286% |
| Peak Bio, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -1002.144% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -3351.264% |
| Neurogene Inc. | 13.37 Million USD | -257.437% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 84.401% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -82.005% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| argenx SE | 15.35 Million USD | -211.32% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -381.37% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -28352.381% |
| Immunome, Inc. | 1.34 Million USD | -3467.164% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 2.33 Million USD | -1947.986% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -4680.0% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -18.001% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -333.282% |
| Athira Pharma, Inc. | 1.21 Million USD | -3827.691% |
| XOMA Corporation | 118.51 Million USD | 59.669% |
| Merus N.V. | 10.48 Million USD | -355.759% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -255.946% |
| Rezolute, Inc. | 1.66 Million USD | -2779.518% |
| Clene Inc. | 7.15 Million USD | -568.345% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -65068.784% |
| BeyondSpring Inc. | 3.36 Million USD | -1320.927% |
| Synlogic, Inc. | 12.49 Million USD | -282.676% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -46.374% |
| Krystal Biotech, Inc. | 6.62 Million USD | -622.054% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | 72.034% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -697.198% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -100805.617% |
| MannKind Corporation | 252.15 Million USD | 81.043% |
| Ikena Oncology, Inc. | 7.18 Million USD | -565.738% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -23920.101% |
| Gossamer Bio, Inc. | 197.4 Million USD | 75.786% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -9092.308% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | 83.009% |
| Mural Oncology plc | 8.91 Million USD | -436.416% |
| Disc Medicine, Inc. | 1.43 Million USD | -3228.691% |
| Champions Oncology, Inc. | 6.09 Million USD | -684.507% |
| REGENXBIO Inc. | 82.22 Million USD | 41.865% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -9576.055% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -978.033% |
| Vaxart, Inc. | 2.62 Million USD | -1722.341% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -17497.402% |
| Cellectis S.A. | 36.24 Million USD | -31.895% |
| Longeveron Inc. | 1.44 Million USD | -3201.105% |
| Repare Therapeutics Inc. | 1.01 Million USD | -4632.673% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 95.779% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -6.77% |
| Revolution Medicines, Inc. | 80.57 Million USD | 40.676% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -1390.025% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -26905.65% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -38761.789% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 93.404% |
| Denali Therapeutics Inc. | 44.98 Million USD | -6.267% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -282.27% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -35281.461% |
| Passage Bio, Inc. | 22.92 Million USD | -108.542% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -691.522% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -7287.944% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -137.044% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -11631.299% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -3923.569% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -10157.511% |
| OmniAb, Inc. | 22.07 Million USD | -116.535% |
| Anew Medical, Inc. | 1.54 Million USD | -3003.896% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -61.705% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -429.171% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -53.747% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -1079.007% |
| G1 Therapeutics, Inc. | 51.55 Million USD | 7.287% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -650.746% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -238.311% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -7013.095% |
| Alumis Inc. Common Stock | 30.86 Million USD | -54.893% |
| Equillium, Inc. | 384 Thousand USD | -12347.917% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -676.1% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dominari Holdings Inc. | 3.02 Million USD | -1478.6% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -241643.792% |
| vTv Therapeutics Inc. | 169 Thousand USD | -28184.024% |
| Bio-Techne Corporation | 319 Million USD | 85.016% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | 16.123% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | 73.231% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -210.249% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -286.013% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -894.383% |
| Nkarta, Inc. | 82.27 Million USD | 41.899% |
| BioCardia, Inc. | 982 Thousand USD | -4767.617% |
| Iterum Therapeutics plc | 18.95 Million USD | -152.163% |